Beacon Pointe Advisors, LLC G1 Therapeutics, Inc. Transaction History

Beacon Pointe Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$2.2 - $4.98 $8,800 - $19,920	-4,000 Reduced 9.15%	39,700 $90,000
Q4 2023 Feb 08, 2024	BUY	$1.12 - $3.73 $784 - $2,611	700 Added 1.63%	43,700 $133,000
Q3 2023 Nov 14, 2023	BUY	$1.22 - $2.67 $52,460 - $114,810	43,000 New	43,000 $61,000
Q3 2022 Nov 09, 2022	BUY	$5.17 - $16.99 $6,721 - $22,086	1,300 Added 10.92%	13,200 $164,000
Q2 2022 Aug 11, 2022	BUY	$4.04 - $8.51 $1,616 - $3,404	400 Added 3.48%	11,900 $58,000
Q1 2022 May 17, 2022	BUY	$7.6 - $11.02 $87,400 - $126,730	11,500 New	11,500 $87,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.